This list is an analysis based on recent market events. It's not an investment recommendation.
About
Curocell Inc., a cell gene therapy development company, engages in the development and manufacturing of pharmaceuticals. It provides research and development services; and OVercome Immune Suppression (OVIS), a proprietary platform technology designed to get away from exhaustion induced by immune checkpoint receptors. The company is also involved in the development of CD19 CAR-T treatment, blood cancer CAR-T, solid cancer CAR-T, and allogeneic CAR-T. Curocell Inc. was founded in 2016 and is headquartered in Daejeon, South Korea.
The current price of 372320.KQ is ₩22,500 KRW — it has decreased by -2.6% in the past 24 hours. Watch Curocell stock price performance more closely on the chart.
What is Curocell stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Curocell stocks are traded under the ticker 372320.KQ.
Is Curocell stock price growing?▼
372320.KQ stock has fallen by -7.79% compared to the previous week, the month change is a -2.17% fall, over the last year Curocell has showed a -40.71% decrease.
How many employees does Curocell have?▼
As of November 3, 2026, the company has 136 employees.
In which sector is Curocell located?▼
Curocell operates in the Other sector.
When did Curocell complete a stock split?▼
Curocell has not had any recent stock splits.
Where is Curocell headquartered?▼
Curocell is headquartered in Daejeon, South Korea.